We use cookies and other tracking technologies to improve your browsing experience on our website, to show you personalized content and targeted ads, to analyze our website traffic, and to understand ...
In terms of the newest collaboration, the health care professionals said they decided that having all the services under one ...
KHQA on MSN9d
Blessing Health introduces new FDA-approved nasal spray treatment for resistant depressionUp to 40% of people who suffer from depression are unable to find any relief for their condition. But now, Blessing ...
Myers Squibb Company, Johnson & Johnson, Bausch Health Companies Inc, AbbVie Inc. Read 's Market Analysis on Investing.com ...
Discover recent clinical trial failures in depression and explore potential pathways for advancing antidepressant drug ...
The 2019 winner of "RuPaul's Drag Race UK," who died in January, had experienced cardiac arrest following ketamine use, The ...
S-ketamine, also called esketamine (Spravato), is a nasal spray with FDA approval for treatment-resistant depression and major depressive disorder with suicidal ideation. Esketamine (Spravato ...
A DMT-based treatment for people with treatment-resistant depression (TRD) has entered Phase 2 clinical trials.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback